Wright Medical — Merger or Acquisition (December 2014)
36 slides from Wright Medical's merger presentation, Dec 2, 2014
Slide 1: The Path to Extraordinary: Transformation and Creating Value Using the High Performance Management System
Columbia School of Business – Investing in Medical Technologies Lecture The Path to Extraordinary: Transformation and Creating Value Using the High Performance Management System Bob Palmisano, President & CEO December 1, 2014
Slide 2: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements This presentation includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “pro
Slide 3: Note on Non-GAAP Financial Measures
Note on Non-GAAP Financial Measures Wright and Tornier use non-GAAP financial measures, including EBITDA, as adjusted. Their respective management teams believe that the presentation of these measures provides useful information to investors and that these measures may assist investors in evaluating
Slide 4: Important Additional Information and Where To Find It
Important Additional Information and Where To Find It In connection with the proposed merger, Tornier plans to file with the U.S. Securities and Exchange Commission (SEC) a registration statement on Form S-4 that will include a joint proxy statement of Wright and Tornier that also constitutes a pros
Slide 5: How I got here
How I got here $2.6B $972M $744M $808M 4
Slide 6: Focus and simplicity (Steve Jobs quote)
That’s been one of my mantras — focus and simplicity. Simple can be harder than complex; you have to work hard to get your thinking clean to make it simple.” Steve Jobs 5
Slide 7: Our company at a Glance
Our company at a Glance Market Cap ~$1.5B NASDAQ: WMGI Extremities-Biologics company with leadership position in Lower Extremities — foot & ankle HQ Memphis, TN 2013 revenue: $242M products in 60 countries 1000 global employees 6
Slide 8: Our products at a Glance
Our products at a Glance Foot & Ankle Growth (Global Constant Currency Sales) 28% 23% INBONE® and INFINITY® 15% Total Ankle Systems 9% ORTHOLOC® Reconstructive Plates 2011 2012 2013 2014 YTD PRO-TOE® Hammertoe Implants 3% 10% Other 25% Upper Extremities Biologics Biologics 62% Foot & Ankle 2013 Sale
Slide 9: Growth had stalled in Extremities
Extended Deferred Prosecution Agreement (DPA) Growth had stalled in Extremities In the past… Low margin Outlook was grim and Cash intensive a break from status Mix 40% Extremities-Bio, 60% Ortho-Recon quo was needed 2010 2011 2012 2013 2014 Status Quo Sales Status Quo EPS 8
Slide 10: Wright Medical: A Company Transformation
Wright Medical: A Company Transformation 2011 2014 Singular Focus Multiple Lines Industry Leader Unclear Strategy High Growth Revenue Decline OrthoRecon R&D International Divestiture Acceleration Expansion Direct F&A MedEd M&A Sales Force Acceleration(5 Acquisitions) TRANSFORMATION 9
Slide 11: Our Differentiated Business Model
Our Differentiated Business Model Unique pure play company Focused on most attractive segments Leveraging strong competitive advantages Delivering industry-leading growth It sounds simple. But it takes clear differentiators and a determined execution 10
Slide 12: Unique Pure Play Company
1 Unique Pure Play Company Broad Product range Other companies Narrow Diversified Single-focus Focus on Extremities-Biologics 11
Slide 13: Focused on Most Attractive, Higher Growth Segments of the Orthopedics Market
2 Focused on Most Attractive, Higher Growth Segments of the Orthopedics Market Foot & Ankle Market Wright Medical focus U.S. = $1.1B 2011-2016 CAGR More concentrated call point Complex treatment issues, less mature products need innovative solutions significant mix opportunity Strong growth drivers
Slide 14: Leveraging Strong Competitive Advantages
3 Leveraging Strong Competitive Advantages Broad foot & ankle product portfolio – the “go to” one stop shop for doctors Strong R&D pipeline – to drive technology adoption Powerful competitive advantages “Sticky” relationships with surgeons – trained ~2,500 surgeons 2013 vs. 600 in 2011 Largest speci
Slide 15: Delivering Industry-Leading Growth
R ESU L T Delivering Industry-Leading Growth Wright 28%(2) Medical growing market growing faster 8-10%(1) fast… Foot & Ankle Wright Medical: Outgrowing a growth market Note 1: Millennium Research Group, Management Estimates Note 2: YTD (September 30, 2014) global constant currency foot & ankle reven
Slide 16: Key initiatives on our pathway to success
5 Targeted M&A 4 ors Expand internationally Best-in-class 3 medical education 2 Launch new products Extremities market Key initiatives on our 1 Increase U.S. sales growing in 8-10% range pathway to success force productivity 15
Slide 17: FDA Approvable Letter for Augment Bone Graft
On October 27, Wright Announced Receipt of FDA Approvable Letter for Augment® Bone Graft First clinically proven cost-effective alternative to autograft for ankle and/or hindfoot fusion — roughly a $300M U.S. market opportunity Final approval subject to customary preapproval inspections Assuming sat
Slide 18: Our next chapter
Our next chapter 17
Slide 19: Wright and Tornier Agree to Merge
October 27, 2014 Wright and Tornier Agree to Merge Creating Premier Global High-Growth Extremities-Biologics Company Combination Will Offer Comprehensive Upper and Lower Extremity Product Portfolio and Broad Global Reach Further Accelerates Growth Opportunities in Three of the Fastest Growing Areas
Slide 20: Wright: A Company Transformation
Wright: A Company Transformation Once integrated 2011 with Tornier, we anticipate: Lower Three Growth Platforms Multiple Lines Extremities Clear Strategy Unclear Strategy Biologics Revenue growth: Mid-teens Revenue growth: Low single digits Adj. EBITDA margins: approaching 20% in 3-4 years Market ca
Slide 21: High Performance Management System (HPMS)
Disciplined, data-driven management system and process High Performance Management System (HPMS) 20
Slide 22: The essence of HPMS
The essence of HPMS delighted BUSINESS customers SUCCESS satisfied shareholders motivated F employees I N BUSINESS SUCCESS A N C I Ensures that the “Vital Few” (versus A L the “Useful Many”) get done well 21
Slide 23: A High Performance System
A High Performance System A STEP-BY-STEP Customer approach to allocating Vision Voice resources, solving problems, making decisions, and Values Employee capturing opportunities Voice Mission Shareholder Voice 22
Slide 24: Time is limited
Time is limited Fill the box with the larger vital projects that GET RESULTS 23
Slide 25: The 8-Step Breakthrough Process
The 8-Step Breakthrough Process™ STEP ANOTHER Select DOING THE RIGHT 1 “Vital Few” Monitor and STEP 8 THINGS RIGHT Recycle if Necessary Execute With STEP 7 Excellence Develop a Transition Plan STEP 6 Define The Desired STEP 5 State & Needed Determine The Processes The Current State STEP 4 & Processe
Slide 26: How does HPMS work?
How does HPMS work? BREAKTHROUGH TICKET(S) SUCCESS TREE To Do The Right Things Right… Guiding Prescriptive ? Values Vision The STI Desired BreakThrough State Directive Process™ Current 5 Mission Customer VITAL - Step 3 State 4 6 Transition Plan Teams 7 Employee FEW What? Quality Step 2 Who? Implemen
Slide 27: Corporate Success Tree
Corporate Success Tree Shared Values Vision The Specialty Orthopaedic Company People Love Passion • Accountability Quality Policy We will meet or exceed the expectations of our customers by complying with Customer Focus requirements, by maintaining the effectiveness of our quality management system,
Slide 28: Typical Current State
Typical Current State A A B A B B A B A B 27
Slide 29: The Desired State
The Desired State If we’re all supposed to pull in the same direction, “it would help if we knew where we are going.—R. Palermo A B 28
Slide 30: Lessons learned along the way
Lessons learned along the way A B 29
Slide 31: Vital Few must be driven by what is transformational
Vital Few—must be driven by what is transformational for Customers, Employees and Shareholders The Current State The Desired State Focused Focused Communication tough lessons along the way 30
Slide 32: If it's ugly, call it ugly
If it’s ugly, call it ugly… No sugar coating Reward Recognition Training Coaching Key Measures The Current State The Desired State Role Model Leaders Focused Focused Strategies Communications tough lessons along the way 31
Slide 33: All elements of plan must be addressed
All elements of plan must be addressed Reward Recognition Training Coaching Key Measures The Current State The Desired State Focused Focused Strategies Role Model Leaders Communications tough lessons along the way 32
Slide 34: Alignment to desired state is critical
Alignment to desired state is critical Reward Recognition Training Coaching Key Measures The Current State The Desired State Focused Focused Strategies Role Model Leaders Communications tough lessons along the way 33
Slide 35: Focused Excellence will propel Wright
Focused Excellence will propel Wright to be the Premier Global High-Growth Extremities-Biologics Company Focused on being a great company! Growth & profitability Build a driven culture of excellence 34
Slide 36: A good plan violently executed now
A good plan violently executed now is better than a perfect plan executed next week. -General George S. Patton It takes time The journey is littered with obstacles Stay true to the system Celebrate the small victories Invest in it to gain momentum Perfection is your enemy 35 Note on Non-GAAP Financi
Wright Medical Group — Merger or Acquisition (December 2014) on 6ix